HAPPENING NOW
The headlines, minus the noise. Updated in real time. Beta
An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug
Business & Economy 
AI Summary Powered by Happening Now AI
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug
Read full article on MarketwatchAI summaries can be wrong sometimes—always verify important details using the source article.
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNow